Nucleo-cytoplasmic shuttling of high risk human Papillomavirus E2 proteins induces apoptosis

被引:64
作者
Blachon, S [1 ]
Bellanger, S [1 ]
Demeret, C [1 ]
Thierry, G [1 ]
机构
[1] Inst Pasteur, Unite Express Genet & Malad, CNRS, FRE 2850, F-75724 Paris, France
关键词
D O I
10.1074/jbc.M505138200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human Papillomavirus (HPV) E2 proteins are the major viral regulators of transcription and replication during the viral life cycle. In addition to these conserved functions, we show that E2 proteins from high risk HPV types 16 and 18, which are associated with cervical cancer, can induce apoptosis. In contrast, E2 proteins from low risk HPV types 6 and 11, which are associated with benign lesions, do not cause cell death. We show that the ability to induce apoptosis is linked to the intracellular localization of the respective E2 proteins rather than to inherent properties of the proteins. Although low risk HPV E2 proteins remain strictly nuclear, high risk HPV E2 proteins are present in both the nucleus and the cytoplasm of expressing cells due to exportin-1 receptor (CRM1)-dependent nucleo-cytoplasmic shuttling. Induction of apoptosis is caused by accumulation of E2 in the cytoplasm and involves caspase 8 activation. We speculate that disruption of the E2 gene during viral genome integration in cervical carcinoma provides a means to avoid E2-induced apoptosis and allow initiation of carcinogenesis.
引用
收藏
页码:36088 / 36098
页数:11
相关论文
共 49 条
[1]   The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2 [J].
Abbate, EA ;
Berger, JM ;
Botchan, MR .
GENES & DEVELOPMENT, 2004, 18 (16) :1981-1996
[2]   Subversion of cell survival and cell death:: viruses as enemies, tools, teachers and allies [J].
Ameisen, JC ;
Pleskoff, O ;
Lelièvre, JD ;
De Bels, F .
CELL DEATH AND DIFFERENTIATION, 2003, 10 (Suppl 1) :S3-S6
[3]   Structure of the intact transactivation domain of the human papillomavirus E2 protein [J].
Antson, AA ;
Burns, JE ;
Moroz, OV ;
Scott, DJ ;
Sanders, CM ;
Bronstein, IB ;
Dodson, GG ;
Wilson, KS ;
Maitland, NJ .
NATURE, 2000, 403 (6771) :805-809
[4]   Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain [J].
Bellanger, S ;
Demeret, C ;
Goyat, S ;
Thierry, F .
JOURNAL OF VIROLOGY, 2001, 75 (16) :7244-7251
[5]  
BELLANGER S, 2005, IN PRESS CELL CYCLE, V4
[6]  
Bogerd HP, 1996, MOL CELL BIOL, V16, P4207
[7]   Viral proteins targeting mitochondria: controlling cell death [J].
Boya, P ;
Pauleau, AL ;
Poncet, D ;
Gonzalez-Polo, RA ;
Zamzami, N ;
Kroemer, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1659 (2-3) :178-189
[8]   REGULATION OF HUMAN PAPILLOMAVIRUS TYPE-11 ENHANCER AND E6 PROMOTER BY ACTIVATING AND REPRESSING PROTEINS FROM THE E2 OPEN READING FRAME - FUNCTIONAL AND BIOCHEMICAL-STUDIES [J].
CHIN, MT ;
HIROCHIKA, R ;
HIROCHIKA, H ;
BROKER, TR ;
CHOW, LT .
JOURNAL OF VIROLOGY, 1988, 62 (08) :2994-3002
[9]  
Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414
[10]   THE E2 TRANSCRIPTIONAL REPRESSOR CAN COMPENSATE FOR SP1 ACTIVATION OF THE HUMAN PAPILLOMAVIRUS TYPE-18 EARLY PROMOTER [J].
DEMERET, C ;
YANIV, M ;
THIERRY, F .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7075-7082